1763 — China Isotope & Radiation Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.46bn
- HK$4.81bn
- CNY6.63bn
- 45
- 90
- 32
- 60
Annual cashflow statement for China Isotope & Radiation, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 734 | 596 | 803 | 921 | — |
| Depreciation | |||||
| Non-Cash Items | -61.3 | -30.3 | -43.6 | -70.7 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -202 | -446 | -162 | -208 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 602 | 292 | 794 | 863 | — |
| Capital Expenditures | -591 | -410 | -428 | -534 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -518 | -14 | -480 | 27.4 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,108 | -424 | -907 | -507 | — |
| Financing Cash Flow Items | 581 | 40.2 | -103 | -157 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 591 | -156 | -97.4 | -291 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 82.8 | -289 | -210 | 64.5 | — |